Clinical Trial: Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122, KEYNOTE-122)
Study Status: Recruiting
Recruit Status:
Study Type:
Official Title:
Brief Summary:
Detailed Summary:
Sponsor:
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By:
Dates:
Date Received:
Date Started:
Date Completion:
Last Updated:
Last Verified:
